Biotech Aptevo Therapeutics Provides Update on Ongoing APVO436 Phase 1 Clinical Trial January 11, 2021
Biotech Cyclacel Pharmaceuticals Reviews 2020 Achievements and Announces Key Business Objectives for 2021 January 11, 2021
Biotech Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference January 11, 2021
Biotech Anavex Life Sciences Receives Michael J. Fox Foundation Grant for Clinical Study of ANAVEX®2-73 (blarcamesine) in People with Parkinson’s Disease January 11, 2021
Biotech Affimed Announces Euro25 Million Debt Financing Agreement with Silicon Valley Bank January 11, 2021
Biotech Aileron Therapeutics Announces Completion of $35.9 Million Registered Direct Offering with Participation by New Fundamental Healthcare Investors Acorn Bioventures, BVF Partners, L.P. and Maven Investment Partners January 11, 2021